Retinoblastoma in the Southern Philippines: Clinical Outcomes of Retinoblastoma Patients in a Davao Tertiary Hospital

Authors

  • Charmaine Grace P. Malabanan-Cabebe, MD Southern Philippines Medical Center, Davao City, Philippines https://orcid.org/0000-0001-9323-3273
  • Melissa Anne Santos-Gonzales, MD Section of Pediatric Ophthalmology and Strabismus, Department of Ophthalmology, Southern Philippines Medical Center, Davao City, Philippines; St. Elizabeth Hospital, Inc., General Santos City, Philippines; General Santos Doctor's Hospital, General Santos City, Philippines
  • Adriel Vincent R. Te, MD Southern Philippines Medical Center, Davao City, Philippines
  • Roland Joseph D. Tan, MD, MS, MIH Department of Ophthalmology and Visual Sciences, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines
  • Jocelyne Gonzales-Sy, MD Southern Philippines Medical Center, Davao City, Philippines; Metro Davao Medical and Research Institute, Davao City, Philippines

DOI:

https://doi.org/10.47895/amp.vi0.6754

Keywords:

retinoblastoma, clinical profile, treatment, outcomes, survival rate, Mindanao

Abstract

Background. Retinoblastoma is the most common intraocular cancer in childhood in the Philippines. Most data
though on demographics, clinical profile, treatment options, and outcomes in the country are from the National
Capital Region.

Objectives. This study aimed to describe the demographics, clinical profile, treatment done, and outcomes of
retinoblastoma patients seen in a public tertiary referral center in Davao from 2011-2020 to make available literature more representative of the status of retinoblastoma in the Philippines.

Methods. An analytical cross-sectional study was conducted using the records of retinoblastoma patients seen in a tertiary government hospital located in Davao Region from January 2011 to December 2020.

Results. There were 157 patients included in the analysis. Seventy-three (46%) were female with 44% coming from the Davao Region. One hundred seven (69%) patients had unilateral disease. Median age at initial consultation for patients with unilateral disease was significantly older than those with bilateral disease (p<0.003). Tumors were extraocular in 82 (40%) eyes. In the intraocular group, 36% of the eyes belonged to International Classification of Retinoblastoma (ICRB) Groups D and E. Enucleation was the most commonly performed treatment. Survival rate was 28%.

This is the first report to provide epidemiologic and clinical data on retinoblastoma in the literature, including survival data, from Mindanao. Advanced stages and extraocular cases of retinoblastoma remain high. Delay of consultation contributed to the prognosis and clinical outcome of the disease.

Conclusion. Advanced stages and extraocular cases of retinoblastoma remain significantly high in the country, even in Mindanao.

 treatment, outcomes, survival rate, Mindanao

 

Author Biographies

  • Melissa Anne Santos-Gonzales, MD, Section of Pediatric Ophthalmology and Strabismus, Department of Ophthalmology, Southern Philippines Medical Center, Davao City, Philippines; St. Elizabeth Hospital, Inc., General Santos City, Philippines; General Santos Doctor's Hospital, General Santos City, Philippines

    Southern Philippines Medical Center, Department of Ophthalmology, Pediatric Ophthalmology and Strabismus Section Head

  • Roland Joseph D. Tan, MD, MS, MIH, Department of Ophthalmology and Visual Sciences, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines

     

     

Downloads

Published

2024-04-15

Issue

Section

Articles

How to Cite

1.
Retinoblastoma in the Southern Philippines: Clinical Outcomes of Retinoblastoma Patients in a Davao Tertiary Hospital. Acta Med Philipp [Internet]. 2024 Apr. 15 [cited 2025 Apr. 5];58(6). Available from: https://actamedicaphilippina.upm.edu.ph/index.php/acta/article/view/6754

Most read articles by the same author(s)